Advanced PET Imaging, Nuclear Medicine, and Therapy: From Diagnostics to Theranostics

Memo

This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.At the conclusion of this course, participants will be able to:- Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT- Describe the logistics of bringing these new diagnostic and therapeutic technologies to clinical practice- Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging- Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT   URLs:Tickets: https://go.evvnt.com/2357369-2?pid=5569 Virtual: https://go.evvnt.com/2357369-3?pid=5569  Date and Time: On Thu, 24 Apr 2025 07:30 - Fri, 25 Apr 2025 16:45 Venue details: Encore At Wynn Las Vegas, 3121 S Las Vegas Blvd, Las Vegas, NV, 89109, United States Prices:Practicing Physician/Industry: USD 1495.00,Military/Retired/Scientist/VA: USD 1295.00,PA/Nurse: USD 1195.00,Resident/Fellow: USD 1095.00,Technologist: USD 995.00 Speakers: Phillip Kuo, MD, PhD, FACR, Andrew Quon, MD, Don C. Yoo, MD